Correlation Between Monopar Therapeutics and Tenax Therapeutics
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Tenax Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Tenax Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Tenax Therapeutics, you can compare the effects of market volatilities on Monopar Therapeutics and Tenax Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Tenax Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Tenax Therapeutics.
Diversification Opportunities for Monopar Therapeutics and Tenax Therapeutics
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monopar and Tenax is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Tenax Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenax Therapeutics and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Tenax Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenax Therapeutics has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Tenax Therapeutics go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Tenax Therapeutics
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 2.37 times more return on investment than Tenax Therapeutics. However, Monopar Therapeutics is 2.37 times more volatile than Tenax Therapeutics. It trades about 0.41 of its potential returns per unit of risk. Tenax Therapeutics is currently generating about 0.43 per unit of risk. If you would invest 1,457 in Monopar Therapeutics on September 1, 2024 and sell it today you would earn a total of 796.00 from holding Monopar Therapeutics or generate 54.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Tenax Therapeutics
Performance |
| Timeline |
| Monopar Therapeutics |
| Tenax Therapeutics |
Monopar Therapeutics and Tenax Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Tenax Therapeutics
The main advantage of trading using opposite Monopar Therapeutics and Tenax Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Tenax Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenax Therapeutics will offset losses from the drop in Tenax Therapeutics' long position.| Monopar Therapeutics vs. Cue Biopharma | Monopar Therapeutics vs. Tff Pharmaceuticals | Monopar Therapeutics vs. Lantern Pharma | Monopar Therapeutics vs. Eliem Therapeutics |
| Tenax Therapeutics vs. Allarity Therapeutics | Tenax Therapeutics vs. Neurobo Pharmaceuticals | Tenax Therapeutics vs. Virax Biolabs Group | Tenax Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |